Association of PICP Serum Marker in Patients With LVSD

NCT00232388 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2015-10-07

No results posted yet for this study

Summary

The purpose of this study is to determine if the carboxy-terminal of procollagen type I (PICP) can be a useful marker of different degrees of myocardial fibrosis.

Conditions

  • Systolic Dysfunction

Interventions

PROCEDURE

Blood draw

Sponsors & Collaborators

  • Texas Tech University Health Sciences Center

    lead OTHER

Principal Investigators

  • Chanwit Roongsritong, MD · TTUHSC

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-09-30
Completion
2007-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00232388 on ClinicalTrials.gov